Cohance Lifesciences shareholding pattern

COHANCE

HealthcareLarge

925

8.10 (-0.87%)
Last updated on 11 Aug, 2025 | 09:02 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Cohance Lifesciences Shareholding Pattern

  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

66.41%

Mutual Fund

8.9%

Insurance

2.27%

Foreign Institutional Investors

7.23%

Domestic Institutional Investors

0.24%

Retail

14.95%

Others

0%

Total Promoters
MAR '25
50.1%
JUN '25
66.41%

Cohance Lifesciences FAQs

As of 08-2025, the promoter shareholding in Cohance Lifesciences stands at 66.41% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Cohance Lifesciences is 7.23% and 0.24% respectively.

The retail shareholding of the Cohance Lifesciences is 14.95%.

Changes in shareholding patterns of Cohance Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Cohance Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.